Gov't to help local vaccine developers, ingredient makers with overseas expansion
President Yoon Suk-yeol, front center, listens to how a liquid nitrogen freezer works to store blood, cells and Deoxyribonucleic acid (DNA) at National Biobank of Korea under the Korea National Institute of Health in Cheongju, North Chungcheong Province, May 26. Korea Times fileBy Lee Kyung-min The government will help local vaccine developers and key pharmaceutical ingredient makers strengthen cooperation with their prospective business partners overseas, mostly in the areas of technical cooperation, raw input material trading supply and exports, officials said, Thursday.The government assistance is buttressed by a rosy global pharmaceutical industry outlook, as presented by the research findings of Airfinity, a global health intelligence and analytics services provider. It said that the COVID-19 vaccine market amounted to $65.6 billion (84.4 trillion won) last year, more than double the size of the non-COVID-19 vaccine market, which stood at $33 billion. KoreaBio, a private organization representing about 600 local firms, said that the COVID-19 vaccine market is expected to grow fu
